Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Cansortium Inc

Healthcare US CNTMF

0.0236USD
-0.0004(1.67%)

Last update at 2026-06-22T17:09:00Z

Day Range

0.020.02
LowHigh

52 Week Range

0.030.09
LowHigh

Fundamentals

  • Previous Close 0.02
  • Market Cap22.31M
  • Volume110200
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA2.65M
  • Revenue TTM104.40M
  • Revenue Per Share TTM0.22
  • Gross Profit TTM 38.37M
  • Diluted EPS TTM-0.14

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -33.70000M -9.15600M -26.77000M -11.35800M -30.39900M
Minority interest - - - - 0.00000M
Net income -40.39000M -22.75000M -37.42300M -19.03900M -36.61900M
Selling general administrative 36.81M 30.81M 27.41M 30.05M 32.12M
Selling and marketing expenses - - - - -
Gross profit 54.56M 47.53M 36.96M 35.79M 29.88M
Reconciled depreciation 14.99M 15.08M 13.43M 9.81M 8.28M
Ebit - - - -0.64300M -8.41500M
Ebitda - - 2.86M 11.66M -8.36300M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income 10.67M 9.31M 2.78M -0.64300M -8.41500M
Other operating expenses - - - - -
Interest expense 20.01M 17.98M 16.21M 13.21M 13.76M
Tax provision 6.69M 13.59M 10.38M 7.65M 6.34M
Interest income 0.06M 0.04M 0.08M 0.28M -
Net interest income -19.95200M -17.94100M -16.08700M -15.76000M -13.76000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - 7.65M 6.34M
Total revenue 103.56M 97.29M 87.69M 65.44M 52.39M
Total operating expenses 92.89M 87.98M 84.91M 66.08M 60.80M
Cost of revenue 49.00M 49.76M 50.73M 29.65M 22.51M
Total other income expense net -24.41700M -0.52400M -13.46700M 5.04M -8.22400M
Discontinued operations - - - -0.03500M 0.12M
Net income from continuing ops -40.39000M -22.75000M -37.14600M -19.00400M -36.73500M
Net income applicable to common shares - - - -19.03900M -36.62000M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 206.99M 177.80M 178.03M 182.46M 154.53M
Intangible assets 37.59M 93.59M 94.29M 95.82M 97.03M
Earning assets - - - - -
Other current assets 1.45M 1.10M - 1.01M 0.22M
Total liab 215.97M 169.22M 150.47M 119.89M 126.70M
Total stockholder equity -8.98200M 8.59M 27.56M 62.57M 27.83M
Deferred long term liab - - - - -
Other current liab 2.15M 9.11M 8.68M 6.08M 16.34M
Common stock - - - 180.66M 137.84M
Capital stock 206.42M 183.69M 180.95M 180.66M 137.84M
Retained earnings -258.21100M -217.82100M -195.07100M -157.64800M -138.60900M
Other liab - - - 21.56M 23.47M
Good will 1.52M 1.52M 1.53M 1.53M 1.53M
Other assets - - - 5.52M 4.28M
Cash 35.61M 10.52M 8.36M 9.02M 3.39M
Cash and equivalents - - - - -
Total current liabilities 71.68M 49.51M 37.96M 23.56M 69.24M
Current deferred revenue - - - - -
Net debt 40.41M 50.88M 49.35M 45.27M 48.37M
Short term debt - - - - -
Short long term debt 0.76M 0.21M 0.74M 0.62M 38.58M
Short long term debt total - - - - -
Other stockholder equity - - - 39.56M 28.61M
Property plant equipment - - - 53.33M 38.61M
Total current assets 61.43M 22.19M 19.24M 23.54M 12.03M
Long term investments - - - - 0.20M
Net tangible assets - - - -34.78200M -70.73000M
Short term investments - - 0.00000M 0.20M -
Net receivables 0.42M 0.21M 0.03M 0.03M 0.39M
Long term debt 75.26M 61.19M 56.97M 53.67M 13.18M
Inventory 18.32M 9.57M 9.97M 12.28M 6.92M
Accounts payable 6.33M 5.53M 6.93M 8.52M 4.81M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.16M 0.91M 0.77M 0.63M 0.42M
Deferred long term asset charges - - - - -
Non current assets total 145.56M 155.61M 158.79M 158.92M 138.85M
Capital lease obligations 56.48M 40.11M 36.05M 23.59M 22.70M
Long term debt total - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments 22.00M -6.33800M -6.77400M -22.11100M -5.86700M
Change to liabilities - - - 3.71M -0.00400M
Total cashflows from investing activities - - - -22.11100M -5.62500M
Net borrowings 6.68M -12.94700M - 4.15M -4.70000M
Total cash from financing activities 6.68M -9.95500M -13.21000M 32.81M -0.34900M
Change to operating activities - - - -2.28300M 2.81M
Net income -40.39000M -22.75000M -37.42300M -19.03900M -36.62000M
Change in cash 30.45M 2.16M -0.66500M 5.63M 0.88M
Begin period cash flow 10.52M 8.36M 9.02M 3.39M 2.52M
End period cash flow 40.11M 10.52M 8.36M 9.02M 3.39M
Total cash from operating activities 1.77M 18.45M 19.07M -5.02600M 6.67M
Issuance of capital stock - 2.99M 0.00000M 18.28M -
Depreciation 14.99M 15.08M 13.43M 5.50M 5.99M
Other cashflows from investing activities - - - -0.73200M -0.43300M
Dividends paid - - - - -
Change to inventory 2.54M -1.54900M -4.42800M -10.63700M 0.35M
Change to account receivables 0.02M -0.18700M -0.00200M 0.12M -0.00400M
Sale purchase of stock - - - - -1.18000M
Other cashflows from financing activities - - - 9.02M 9.02M
Change to netincome - - - 24.41M 26.71M
Capital expenditures 17.50M 6.34M 6.80M 21.06M 5.19M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -28.27000M 10.57M 5.85M -15.89300M 10.39M
Stock based compensation 0.54M 0.64M 0.55M 4.30M 5.74M
Other non cash items -20.73600M 28.73M 31.14M 20.05M 11.34M
Free cash flow -15.73100M 12.12M 12.27M -26.40500M 2.90M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CNTMF
Cansortium Inc		 -0.0004 1.67% 0.02 - 1.03 0.21 8.65 1.66 3.63
ZTS
Zoetis Inc		 -2.82 3.58% 75.89 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 -0.19 0.62% 30.56 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 - -% 157.12 21.73 14.95 3.16 2.15 3.56 12.82
GALDY
GALDERMA GROUP AG		 - -% 42.94 74.21 41.67 8.64 5.55 9.15 42.22

Reports Covered

Stock Research & News

View All

Profile

FLUENT Corp., through its subsidiaries, cultivates, manufactures processes, distributes, and sells medical cannabis products for medical and adult-use markets in Florida, New York, Pennsylvania, and Texas. The company's medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flower, pre-rolls, cartridges, concentrates, edibles, and other accessories under the Fluent brand name. It also sells various third-party branded medical cannabis products. The company was formerly known as Cansortium Inc. and changed its name to FLUENT Corp. in February 2025. FLUENT Corp. was incorporated in 2018 and is headquartered in Tampa, Florida.

Cansortium Inc

5540 West Executive Drive, Tampa, FL, United States, 33609

Key Executives

Name Title Year Born
Mr. William M. Smith Exec. Chairman NA
Mr. Robert Beasley CEO & Director NA
Ms. Samantha Senne Hymes Exec. VP of Operations NA
Mr. Todd A. Buchman Chief Legal Officer & Corp. Sec. NA
Mr. Victor Bindi Director of Sales NA
Ms. Patricia Fonseca Exec. Officer NA
Ms. Liora Boudin Corp. Controller & Interim CFO NA
Samantha Senne Exec. VP of Operations NA
Dr. Jennifer McCafferty-Fernandez Chief Science Officer NA
Mr. Jeffrey Reath Consultant NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.